Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
EAST RUTHERFORD, N.J., July 7, 2026 /CNW/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Snapdragon Chemistry, a Cambrex company, together with NewAmsterdam Pharma, has received the…
Broker's Call: Mankind Pharma (Add)
After years of growth led by distribution reach and prescription volume, Mankind Pharma is re-orienting towards research-led, niche and specialty therapies where competition is thinner. A calculated move into low-competition specialty niches is a…
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
MUMBAI, India, July 7, 2026 /CNW/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global…
Torrent Pharma, JB Chemicals hit 52-week highs after NCLT approves merger
Shares of Torrent Pharmaceuticals and JB Chemicals & Pharmaceuticals surged to fresh 52-week highs on Tuesday after the National Company Law Tribunal's Ahmedabad Bench sanctioned the merger of JB Chemicals into Torrent Pharmaceuticals on Monday…
Swedbank AB Sells 355,450 Shares of Royalty Pharma PLC $RPRX
Swedbank AB reduced its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 3.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,586,693 shares of…
Y Intercept Hong Kong Ltd Grows Stake in Royalty Pharma PLC $RPRX
Y Intercept Hong Kong Ltd grew its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 1,294.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 73,339 shares of…
Five Ways AI Is Transforming Healthcare Marketing
Kamya Elawadhi is Co-Founder and President at Doceree. Healthcare marketing has always been complex. The audiences are more specialized than in almost any other industry, every interaction lives inside a strict regulatory environment and the…
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Eli Lilly (LLY) shares hit a record high Tuesday after IPO stock Kailera Therapeutics posted lackluster test results for its weight-loss pill. Kailera's partner, Hengrui Pharma, ran two studies in patients in China. But the results seemingly paled…
Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics
PRESS RELEASE, July 07, 2026 – 08:00 CDT Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics ITASCA, IL, US and HUNTSVILLE, AL, US – July 07, 2026. Today, Biocartis, an…
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada
Based on regulatory agency feedback, the Company plans a registrational study that will evaluate hospitalization as the primary outcome measure, supported by multiple functional assessments as secondary outcome measures. LONDON, July 6, 2026 /CNW/…
Jim Cramer says these are the 5 stocks to buy during this market rotation
CNBC's Jim Cramer said investors should use the latest market rotation as an opportunity to buy high-quality companies that were swept lower by broad institutional selling. He highlighted Johnson & Johnson, PepsiCo, Starbucks, Constellation Brands…
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock's Asembia Buy
News The Cigna Group's Evenorth health services business has committed $100 million to support a new artificial intelligence-powered pharmacy program and a private equity firm's purchase of Asembia are only the latest in a wave of huge investments…
IDEXX Laboratories Does Not Need More Vet Visits--But It Needs More Tests Per Visit (NASDAQ:IDXX)
IDEXX Laboratories (IDXX) is rated Hold, as its premium valuation (~38x 2026E EPS) already assumes strong recurring revenue and diagnostics growth. IDXX is growing diagnostics revenue despite declining veterinary visits, leveraging inVue Dx and…
Alpha Tau Medical: Alpha Particles Are Still Interesting, But Beware The Hype (NASDAQ:DRTS)
Alpha Tau Medical (DRTS) pioneers alpha emitter-based targeted radiation therapy, aiming for highly localized tumor destruction with minimal systemic toxicity. DRTS's Alpha DaRT platform is advancing in recurrent cutaneous squamous cell carcinoma…
Apollo economist warns AI profit gains outside tech could take 'well beyond' what Wall Street expects
Outside tech, there's no sign AI is boosting profit margins, writes Torsten Slok, chief economist at US financial firm Apollo. AI company valuations rest entirely on the promise of rising margins at S&P 493 companies (the index minus 'the…
Receive a Daily briefing on Pharma Industry News
Get Started